Fusion Pharmaceuticals Inc. Business Finance Contracts & Agreements

22 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to Open Market Sale Agreement between Fusion Pharmaceuticals Inc. and Jefferies LLC
Modification Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2024
Registration Rights Agreement between Fusion Pharmaceuticals Inc. and Investors (May 10, 2023)
Registration Rights Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Securities Purchase Agreement between Fusion Pharmaceuticals Inc. and Investors (May 10, 2023)
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Registration Rights Agreement between Fusion Pharmaceuticals Inc. and Investors (February 13, 2023)
Registration Rights Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Securities Purchase Agreement between Fusion Pharmaceuticals Inc. and Investors (February 13, 2023)
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Option and Asset Purchase Agreement between RadioMedix, Inc. and Fusion Pharmaceuticals Inc. (November 14, 2022)
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
TX
2023
Registration Rights Agreement between Fusion Pharmaceuticals Inc. and Investors (February 13, 2023)
Registration Rights Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Securities Purchase Agreement between Fusion Pharmaceuticals Inc. and Investors (February 13, 2023)
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2023
Option and Asset Purchase Agreement between RadioMedix, Inc. and Fusion Pharmaceuticals Inc. (November 14, 2022)
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
TX
2023
Second Amendment to Loan and Security Agreement among Oxford Finance LLC, Oxford Finance Credit Fund II, LP, and Fusion Pharmaceuticals Inc.
Loan Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2022
Consent and First Amendment to Loan and Security Agreement among Oxford Finance LLC, Fusion Pharmaceuticals Inc., and Fusion Pharmaceuticals US Inc.
Modification Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2022
Loan and Security Agreement among Oxford Finance LLC, Fusion Pharmaceuticals Inc., and Fusion Pharmaceuticals US Inc. dated April 4, 2022
Loan Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2022
Second Amendment to Asset Purchase Agreement among Fusion Pharmaceuticals, Rainier Therapeutics, and Fortis Advisors (Feb. 8, 2021)
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2021
Description of Registered Securities of Fusion Pharmaceuticals Inc. under Section 12 of the Exchange Act
Equity Distribution Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2021
Asset Purchase Agreement between Ipsen Pharma SAS and Fusion Pharmaceuticals Inc. dated March 1, 2021
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2021
Amendment No. 1 to Asset Purchase Agreement among Fusion Pharmaceuticals, Inc., Rainier Therapeutics, Inc., and Fortis Advisors LLC
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
DE
2020
Stock Certificate Assignment and Transfer Form
Assignment Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
Underwriting Agreement for Common Shares between Fusion Pharmaceuticals Inc. and Underwriters (Morgan Stanley, Jefferies, Cowen)
Underwriting Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2020
Asset Purchase Agreement among Fusion Pharmaceuticals Inc., Rainier Therapeutics, Inc., and Fortis Advisors LLC (March 10, 2020)
Purchase Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2020
Fusion Pharmaceuticals Inc. Class B Preferred Share Purchase Warrant Certificate (2020)
Warrant Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
Warrant Certificate for Class B Preferred Exchangeable Share Purchase Warrants – Fusion Pharmaceuticals (Ireland) Limited
Warrant Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
2020
Amended and Restated Investors' Rights Agreement among Fusion Pharmaceuticals Inc., Fusion Pharmaceuticals (Ireland) Limited, and Certain Shareholders (March 25, 2019)
Investor Rights Agreements
Fusion Pharmaceuticals Inc.
Biotechnology
NY
2020